{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:14:35Z","timestamp":1793661275175,"version":"4.5.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T00:00:00Z","timestamp":1599264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T00:00:00Z","timestamp":1599264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      (1,3)-\u03b2-\n                      <jats:sc>d<\/jats:sc>\n                      -Glucan has been widely used in clinical practice for the diagnosis of invasive\n                      <jats:italic>Candida<\/jats:italic>\n                      infections. However, such serum biomarker showed potential to guide antimicrobial therapy in order to reduce the duration of empirical antifungal treatment in critically ill septic patients with suspected invasive candidiasis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This was a single-centre, randomized, open-label clinical trial in which critically ill patients were enrolled during the admission to the intensive care unit (ICU). All septic patients who presented invasive\n                      <jats:italic>Candida<\/jats:italic>\n                      infection risk factors and for whom an empirical antifungal therapy was commenced were randomly assigned (1:1) in those stopping antifungal therapy if (1,3)-\u03b2-\n                      <jats:sc>d<\/jats:sc>\n                      -glucan was negative ((1,3)-\u03b2-\n                      <jats:sc>d<\/jats:sc>\n                      -glucan group) or those continuing the antifungal therapy based on clinical rules (control group). Serum 1,3-\u03b2-\n                      <jats:sc>d<\/jats:sc>\n                      -glucan was measured at the enrolment and every 48\/72\u2009h over 14\u2009days afterwards. The primary endpoint was the duration of antifungal treatment in the first 30\u2009days after enrolment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We randomized 108 patients into the (1,3)-\u03b2-\n                      <jats:sc>d<\/jats:sc>\n                      -glucan (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200953) and control (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200955) groups. Median [IQR] duration of antifungal treatment was 2\u2009days [1\u20133] in the (1,3)-\u03b2-\n                      <jats:sc>d<\/jats:sc>\n                      -glucan group vs. 10\u2009days [6\u201313] in the control group (between-group absolute difference in means, 6.29\u2009days [95% CI 3.94\u20138.65],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Thirty-day mortality was similar (28.3% [(1,3)-\u03b2-\n                      <jats:sc>d<\/jats:sc>\n                      -glucan group] vs. 27.3% [control group],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.92) as well as the overall rate of documented candidiasis (11.3% [(1,3)-\u03b2-\n                      <jats:sc>d<\/jats:sc>\n                      -glucan group] vs. 12.7% [control group],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.94), the length of mechanical ventilation (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.97) and ICU stay (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.23).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      In critically ill septic patients admitted to the ICU at risk of invasive candidiasis, a (1,3)-\u03b2-\n                      <jats:sc>d<\/jats:sc>\n                      -glucan-guided strategy could reduce the duration of empirical antifungal therapy. However, the safety of this algorithm needs to be confirmed in future, multicentre clinical trial with a larger population.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov,\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03117439?term=de+pascale&amp;draw=2&amp;rank=2\">NCT03117439<\/jats:ext-link>\n                      , retrospectively registered on 18 April 2017\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13054-020-03265-y","type":"journal-article","created":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T04:03:22Z","timestamp":1599278602000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["(1,3)-\u03b2-d-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: a randomized trial"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8255-0676","authenticated-orcid":false,"given":"Gennaro","family":"De Pascale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brunella","family":"Posteraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"D\u2019Arrigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Spinazzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Gaspari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca Maria","family":"Montini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore Lucio","family":"Cutuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico Luca","family":"Grieco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Di Gravio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"De Angelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Torelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"De Carolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Tumbarello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Sanguinetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,5]]},"reference":[{"issue":"9","key":"3265_CR1","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1093\/cid\/ciu074","volume":"58","author":"L Ostrosky-Zeichner","year":"2014","unstructured":"Ostrosky-Zeichner L, Shoham S, Vazquez J, Reboli A, Betts R, Barron M, Schuster M, Judson M, Revankar S, Caeiro J, et al. MSG-01: a randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting. Clin Infect Dis. 2014;58(9):1219\u201326.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"3265_CR2","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1097\/01.CCM.0000202208.37364.7D","volume":"34","author":"C Le\u00f3n","year":"2006","unstructured":"Le\u00f3n C, Ruiz-Santana S, Saavedra P, Almirante B, Nolla-Salas J, Alvarez-Lerma F, Garnacho-Montero J, Le\u00f3n M, EPCAN Study Group. A bedside scoring system (\u201cCandida score\u201d) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med. 2006;34(3):730\u20137.","journal-title":"Crit Care Med"},{"issue":"5","key":"3265_CR3","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1097\/CCM.0b013e31819daa14","volume":"37","author":"C Le\u00f3n","year":"2009","unstructured":"Le\u00f3n C, Ruiz-Santana S, Saavedra P, Galv\u00e1n B, Blanco A, Castro C, Balasini C, Utande-V\u00e1zquez A, Gonz\u00e1lez de Molina F, Blasco-Navalproto M, et al. Usefulness of the \u201cCandida score\u201d for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med. 2009;37(5):1624\u201333.","journal-title":"Crit Care Med"},{"issue":"6","key":"3265_CR4","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1097\/00000658-199412000-00008","volume":"220","author":"D Pittet","year":"1994","unstructured":"Pittet D, Monod M, Suter P, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg. 1994;220(6):751\u20138.","journal-title":"Ann Surg"},{"issue":"10","key":"3265_CR5","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s00134-014-3355-z","volume":"40","author":"P Eggimann","year":"2014","unstructured":"Eggimann P, Pittet D. Candida colonization index and subsequent infection in critically ill surgical patients: 20 years later. Intensive Care Med. 2014;40(10):1429\u201348.","journal-title":"Intensive Care Med"},{"issue":"6","key":"3265_CR6","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00134-019-05599-w","volume":"45","author":"I Martin-Loeches","year":"2019","unstructured":"Martin-Loeches I, Antonelli M, Cuenca-Estrella M, Dimopoulos G, Einav S, De Waele J, Garnacho-Montero J, Kanj S, Machado F, Montravers P, et al. ESICM\/ESCMID task force on practical management of invasive candidiasis in critically ill patients. Intensive Care Med. 2019;45(6):789\u2013805.","journal-title":"Intensive Care Med"},{"issue":"4","key":"3265_CR7","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/cid\/civ1194","volume":"62","author":"P Pappas","year":"2016","unstructured":"Pappas P, Kauffman C, Andes D, Clancy C, Marr K, Ostrosky-Zeichner L, Reboli A, Schuster M, Vazquez J, Walsh T, et al. Executive summary: clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62(4):409\u201317.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"3265_CR8","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1097\/CCM.0b013e318236f297","volume":"40","author":"E Azoulay","year":"2012","unstructured":"Azoulay E, Dupont H, Tabah A, Lortholary O, Stahl J, Francais A, Martin C, Guidet B, Timsit J. Systemic antifungal therapy in critically ill patients without invasive fungal infection*. Crit Care Med. 2012;40(3):813\u201322.","journal-title":"Crit Care Med"},{"issue":"15","key":"3265_CR9","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1001\/jama.2016.14655","volume":"316","author":"J Timsit","year":"2016","unstructured":"Timsit J, Azoulay E, Schwebel C, Charles P, Cornet M, Souweine B, Klouche K, Jaber S, Trouillet J, Bruneel F, et al. Empirical micafungin treatment and survival without invasive fungal infection in adults with ICU-acquired sepsis, Candida colonization, and multiple organ failure: the EMPIRICUS randomized clinical trial. JAMA. 2016;316(15):1555\u201364.","journal-title":"JAMA"},{"issue":"1","key":"3265_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13613-018-0392-8","volume":"8","author":"K Jaffal","year":"2018","unstructured":"Jaffal K, Poissy J, Rouze A, Preau S, Sendid B, Cornu M, Nseir S. De-escalation of antifungal treatment in critically ill patients with suspected invasive Candida infection: incidence, associated factors, and safety. Ann Intensive Care. 2018;8(1):49.","journal-title":"Ann Intensive Care"},{"issue":"3","key":"3265_CR11","doi-asserted-by":"publisher","first-page":"R135","DOI":"10.1186\/cc13953","volume":"18","author":"J Poissy","year":"2014","unstructured":"Poissy J, Sendid B, Damiens S, Ishibashi KI, Fran\u00e7ois N, Kauv M, Favory R, Mathieu D, Poulain D. Presence of Candida cell wall derived polysaccharides in the sera of intensive care unit patients: relation with candidaemia and Candida colonisation. Crit Care. 2014;18(3):R135.","journal-title":"Crit Care"},{"issue":"8","key":"3265_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042282","volume":"7","author":"K Hanson","year":"2012","unstructured":"Hanson K, Pfeiffer C, Lease E, Balch A, Zaas A, Perfect J, Alexander B. \u03b2-D-glucan surveillance with preemptive anidulafungin for invasive candidiasis in intensive care unit patients: a randomized pilot study. PLoS One. 2012;7(8):e42282.","journal-title":"PLoS One"},{"issue":"9","key":"3265_CR13","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1093\/jac\/dkw188","volume":"71","author":"M Nucci","year":"2016","unstructured":"Nucci M, Nou\u00e9r S, Esteves P, Guimar\u00e3es T, Breda G, de Miranda B, Queiroz-Telles F, Colombo A. Discontinuation of empirical antifungal therapy in ICU patients using 1,3-\u03b2-d-glucan. J Antimicrob Chemother. 2016;71(9):2628\u201333.","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"3265_CR14","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1007\/s00134-015-3922-y","volume":"41","author":"E Mart\u00edn-Mazuelos","year":"2015","unstructured":"Mart\u00edn-Mazuelos E, Loza A, Castro C, Mac\u00edas D, Zakariya I, Saavedra P, Ruiz-Santana S, Mar\u00edn E, Le\u00f3n C. \u03b2-D-Glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis. Intensive Care Med. 2015;41(8):1424\u201332.","journal-title":"Intensive Care Med"},{"issue":"12","key":"3265_CR15","first-page":"3488","volume":"73","author":"R Rautemaa-Richardson","year":"2018","unstructured":"Rautemaa-Richardson R, Rautemaa V, Al-Wathiqi F, Moore C, Craig L, Felton T, Muldoon E. Impact of a diagnostics-driven antifungal stewardship programme in a UK tertiary referral teaching hospital. J Antimicrob Chemother. 2018;73(12):3488\u201395.","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"3265_CR16","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1007\/s00134-017-4932-8","volume":"43","author":"A Rouz\u00e9","year":"2017","unstructured":"Rouz\u00e9 A, Loridant S, Poissy J, Dervaux B, Sendid B, Cornu M, Nseir S. S-TAFE study group: biomarker-based strategy for early discontinuation of empirical antifungal treatment in critically ill patients: a randomized controlled trial. Intensive Care Med. 2017;43(11):1668\u201377.","journal-title":"Intensive Care Med"},{"issue":"5","key":"3265_CR17","doi-asserted-by":"publisher","first-page":"R249","DOI":"10.1186\/cc10507","volume":"15","author":"B Posteraro","year":"2011","unstructured":"Posteraro B, De Pascale G, Tumbarello M, Torelli R, Pennisi M, Bello G, Maviglia R, Fadda G, Sanguinetti M, Antonelli M. Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1\u21923)-\u03b2-D-glucan assay, Candida score, and colonization index. Crit Care. 2011;15(5):R249.","journal-title":"Crit Care"},{"issue":"8","key":"3265_CR18","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1093\/jac\/dkw112","volume":"71","author":"B Posteraro","year":"2016","unstructured":"Posteraro B, Tumbarello M, De Pascale G, Liberto E, Vallecoccia M, De Carolis E, Di Gravio V, Trecarichi E, Sanguinetti M, Antonelli M. (1,3)-\u03b2-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study. J Antimicrob Chemother. 2016;71(8):2262\u20139.","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"3265_CR19","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman C, Seymour C, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard G, Chiche J, Coopersmith C, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801\u201310.","journal-title":"JAMA"},{"issue":"3","key":"3265_CR20","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","volume":"43","author":"A Rhodes","year":"2017","unstructured":"Rhodes A, Evans L, Alhazzani W, Levy M, Antonelli M, Ferrer R, Kumar A, Sevransky J, Sprung C, Nunnally M, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304\u201377.","journal-title":"Intensive Care Med"},{"issue":"1","key":"3265_CR21","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1016\/S1473-3099(17)30304-3","volume":"17","author":"A Colombo","year":"2017","unstructured":"Colombo A, de Almeida JJ, Slavin M, Chen S, Sorrell T. Candida and invasive mould diseases in non-neutropenic critically ill patients and patients with haematological cancer. Lancet Infect Dis. 2017;17(1):e344\u201356.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"3265_CR22","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s13054-017-1763-5","volume":"21","author":"D Giacobbe","year":"2017","unstructured":"Giacobbe D, Mikulska M, Tumbarello M, Furfaro E, Spadaro M, Losito A, Mesini A, De Pascale G, Marchese A, Bruzzone M, et al. Combined use of serum (1,3)-\u03b2-D-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units. Crit Care. 2017;21(1):176.","journal-title":"Crit Care"},{"issue":"9","key":"3265_CR23","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1164\/rccm.201211-2069OC","volume":"188","author":"F Tissot","year":"2013","unstructured":"Tissot F, Lamoth F, Hauser P, Orasch C, Fl\u00fcckiger U, Siegemund M, Zimmerli S, Calandra T, Bille J, Eggimann P, et al. \u03b2-Glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis. Am J Respir Crit Care Med. 2013;188(9):1100\u20139.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"3265_CR24","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1093\/jac\/dkv090","volume":"70","author":"M Mart\u00ednez-Jim\u00e9nez","year":"2015","unstructured":"Mart\u00ednez-Jim\u00e9nez M, Mu\u00f1oz P, Valerio M, Alonso R, Martos C, Guinea J, Bouza E. Candida biomarkers in patients with candidaemia and bacteraemia. J Antimicrob Chemother. 2015;70(8):2354\u201361.","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"3265_CR25","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1164\/rccm.201409-1701OC","volume":"191","author":"S Bailly","year":"2015","unstructured":"Bailly S, Bouadma L, Azoulay E, Orgeas M, Adrie C, Souweine B, Schwebel C, Maubon D, Hamidfar-Roy R, Darmon M, et al. Failure of empirical systemic antifungal therapy in mechanically ventilated critically ill patients. Am J Respir Crit Care Med. 2015;191(10):1139\u201346.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"3265_CR26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13613-015-0103-7","volume":"6","author":"O Leroy","year":"2016","unstructured":"Leroy O, Bailly S, Gangneux J, Mira J, Devos P, Dupont H, Montravers P, Perrigault P, Constantin J, Guillemot D, et al. Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study. Ann Intensive Care. 2016;6(1):2.","journal-title":"Ann Intensive Care"},{"issue":"8","key":"3265_CR27","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1093\/cid\/civ1199","volume":"62","author":"A Tabah","year":"2016","unstructured":"Tabah A, Cotta M, Garnacho-Montero J, Schouten J, Roberts J, Lipman J, Tacey M, Timsit J, Leone M, Zahar J, et al. A systematic review of the definitions, determinants, and clinical outcomes of antimicrobial de-escalation in the intensive care unit. Clin Infect Dis. 2016;62(8):1009\u201317.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"3265_CR28","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/myc.12432","volume":"59","author":"B Liss","year":"2016","unstructured":"Liss B, Cornely O, Hoffmann D, Dimitriou V, Wisplinghoff H. 1,3-\u00df-D-glucan concentrations in blood products predict false positive post-transfusion results. Mycoses. 2016;59(1):39\u201342.","journal-title":"Mycoses"},{"issue":"4","key":"3265_CR29","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1093\/jac\/dkv419","volume":"71","author":"B Liss","year":"2016","unstructured":"Liss B, Cornely O, Hoffmann D, Dimitriou V, Wisplinghoff H. 1,3-\u03b2-D-Glucan contamination of common antimicrobials. J Antimicrob Chemother. 2016;71(4):913\u20135.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"3265_CR30","first-page":"408","volume":"74","author":"S Bailly","year":"2017","unstructured":"Bailly S, Leroy O, Azoulay E, Montravers P, Constantin J, Dupont H, Guillemot D, Lortholary O, Mira J, Perrigault P, et al. Impact of echinocandin on prognosis of proven invasive candidiasis in ICU: a post-hoc causal inference model using the AmarCAND2 study. J Inf Secur. 2017;74(4):408\u201317.","journal-title":"J Inf Secur"},{"issue":"6","key":"3265_CR31","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1097\/QCO.0000000000000497","volume":"31","author":"K Urbancic","year":"2018","unstructured":"Urbancic K, Thursky K, Kong D, Johnson P, Slavin M. Antifungal stewardship: developments in the field. Curr Opin Infect Dis. 2018;31(6):490\u20138.","journal-title":"Curr Opin Infect Dis"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-020-03265-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-020-03265-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-020-03265-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T19:31:02Z","timestamp":1630783862000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-020-03265-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,5]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3265"],"URL":"https:\/\/doi.org\/10.1186\/s13054-020-03265-y","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,5]]},"assertion":[{"value":"23 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocol was approved by the Universit\u00e0 Cattolica del Sacro Cuore Ethics Committee (approval number UCSC20980\/16), and written informed consent was obtained from the patient or the legally authorized representative.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None declared.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"550"}}